MSD | City Cancer Challenge | Melanoma Patient Network Europe ADVOCACY
Colombia, Mexico, Argentina and Paraguay. After conducting a needs assessment, the partnership helps to implement a cancer care roadmap in each city and seeks to address priority gaps in care and build local capacity. A CALL TO ACTION In global health, the increased focus on non-communicable diseases by the World Health Organization and United Nations is a welcome step. However, we are calling on global leaders to go further – to support the development of a Global Cancer Plan to tackle the unique challenges of cancer across all territories. A Global Cancer Plan has the power to secure the global political attention
proportionate to the level of burden created by cancer across the world, while supporting individual countries to develop context specific solutions. It would provide a holistic framework with recommendations on how to address common policy challenges like those outlined above. The process of building the plan would enable learnings and best practices to be shared, encouraging open conversations about how they have tackled key issues. Most importantly, it would prioritise cancer as a critical global health issue, highlighting the need for action. *Merck & Co. Inc., Rahway, New Jersey, United States of America and its affiliates.
A COORDINATED GLOBAL SOLUTION There has been an increase in local, country, regional and global cancer strategies and initiatives, demonstrating recognition of the need to address the alarming growth in cancer rates. We have seen a rise in the number of national cancer control plans (121 as of January 2023), and the introduction of bold policies to standardise cancer strategies across regions such as the EU Beating Cancer Plan. Additionally, collaborations across sectors, such as the City Cancer Challenge partnership with MSD, aim to tackle the growing cancer burden at a municipal level by working with local actors in six cities across countries in Latin America, including Brazil, Peru,
SARAH AIOSA Sarah Aiosa is president for Latin America at MSD. Since early 2022, she has set the strategic direction and managed profit and loss for
ISABEL MESTRES Isabel Mestres is CEO of City Cancer Challenge (C/Can),
DR BETTINA RYLL Dr Bettina Ryll founded the Melanoma Patient Network Europe after her husband’s death from melanoma in 2012. She was a member of
which delivers tailored solutions to enhance healthcare capacity at the city level. Improvements are reflected in national policy, practice guidelines and ways of working. C/Can’s partnerships aim to build advocates, role models and change-makers.
human health across the Latin American region, encompassing 5,000 employees in more than 30 countries.
the first EU Cancer Mission board, and work package co-lead of the World Health Organization Europe Novel Medicines Platform.
53
globalgovernanceproject.org
2024 — G20 BRAZIL: THE RIO SUMMIT
Made with FlippingBook. PDF to flipbook with ease